Rehab At Shannondell in Audubon, PA

Rehab At Shannondell is a medicare certified nursing home in Audubon, Pennsylvania. It is located in Montgomery county at 5000 Shannondell Drive, Audubon, Pennsylvania 19403. You can reach out to the office of Rehab At Shannondell via phone at (610) 728-5400. This skilled nursing facility has 120 federally certified beds with average occupancy rate of 52%. The nursing facility is classified as "Continuing Care Retirement Community" by CMS and its legal business name is Shannondell, Inc. and has the following ownership type - For Profit - Corporation.

Rehab At Shannondell (Medicare CCN 396101) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in medicare program. This means if you are part of medicare program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 2006 (18 years certified) and the last quality survey was conducted in October, 2019.

Name	Rehab At Shannondell
Location	5000 Shannondell Drive, Audubon, Pennsylvania
Certified By	Medicare
No. of Certified Beds	120
Occupancy Rate	52%
Medicare ID (CCN)	396101
Legal Business Name	Shannondell, Inc.
Ownership Type	For Profit - Corporation

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Rehab At Shannondell from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.
Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Rehab At Shannondell are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Rehab At Shannondell give to their patients.

Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

New editorial offers clarity on confusing drug and alcohol addiction terminology

A new editorial released this week offers clarity and structure on confusing drug and alcohol addiction terminology for prescribers, users and regulators. "Through a glass darkly: can we improve clarity about mechanism and aims of medications in drug and alcohol treatments?" is published in the Journal of Psychopharmacology, the official journal of the British Association for Psychopharmacology, published by SAGE.

NOXXON completes patient recruitment of NOX-E36 Phase IIa trial for treatment of diabetic nephropathy

NOXXON Pharma today announced the successful completion of patient recruitment of its NOX-E36 Phase IIa clinical trial for the treatment of diabetic nephropathy. NOX-E36 is a Spiegelmer® that binds and neutralizes CCL2/MCP-1 (C-C Chemokine Ligand / Monocyte Chemoattractant Protein-1), a pro-inflammatory chemokine that plays an important role in the progression of diabetic nephropathy, the most common single cause of chronic kidney failure and end-stage renal disease.

Review of recent advances in stem cell biology

Advances in stem cell research will provide enormous opportunities for both biological and future clinical applications.

Itching after burns - study offers best options

Jim Mashburn felt his legs cook. Mr. Mashburn, a worker at a paper-recycling plant, fell through a loose grate and into a sump pit in September 2008 as he was preparing to inspect a steam valve. Super hot condensate, at a temperature of at least 140 degrees Fahrenheit, enveloped his legs instantly, searing skin up to his thighs.

Read more Medical News

› Verified 3 days ago

Number of Facility Reported Incidents	0
Number of Substantiated Complaints	0
Number of Fines	0
Total Amount of Fines in Dollars	$0
Number of Payment Denials	0
Total Number of Penalties	0

The resident survey data of Rehab At Shannondell is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience Measure	Provider	National Avg.